GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.

GSK plc (LSE/NYSE: GSK) and the University of Oxford (Oxford) today announced that they have entered a new research ...

GSK plc (LSE/NYSE: GSK) today announced that the European Medicines Agency (EMA) has accepted for review the regulatory application of a prefilled syringe presentation of Shingrix (GSK’s Recombinant ...

A new cancer vaccine is being developed which scientists hope could target the disease before it takes hold. The University ...

New cancer vaccine to stop disease before it takes hold in the body - Pharmaceutical giant GSK and the University of Oxford ...